Platinum Industries Ltd

📈 Platinum Industries Expands into Pharma with New Subsidiary Rivadu Lifesciences

• New subsidiary Rivadu Lifesciences Private Limited incorporated on March 18, 2026

• Focuses on pharmaceutical and lifesciences manufacturing and distribution

• Will produce APIs, intermediates, excipients, and finished products including tablets, capsules, injectables, biosimilars, and vaccines

• Platinum Industries invested ₹25,00,000 by subscribing to 250,000 equity shares at ₹10 face value each

• Parent company holds 100% of initial paid-up share capital